These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2148976)

  • 1. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
    Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
    Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
    Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hormone receptor concentration and tumor shrinkage in uterine myoma after treatment with a GnRHa.
    Wang PH; Lee WL; Chao HT; Shu LP; Kao HL; Wu CW; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):294-9. PubMed ID: 10389284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of the content of estrogen and progesterone receptors in uterine myoma and the myometrium].
    Kozachenko AV; Landekhovskiĭ IuD; Kondrikov NI; Kushlinskiĭ NE; Gershteĭn ES
    Akush Ginekol (Mosk); 1995; (6):34-6. PubMed ID: 8779352
    [No Abstract]   [Full Text] [Related]  

  • 9. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
    van Leusden HA; Dogterom AA
    Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment.
    Monsonego J; Destable MD; De Saint Florent G; Amouroux J; Kouyoundjian JC; Haour F; Breau JL; Israel L; Comaru-Schally AM; Schally AV
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1181-9. PubMed ID: 1852100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
    van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
    Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
    Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
    Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
    George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV
    Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy].
    Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J
    Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels.
    Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E
    Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.